|
Name |
pipecolisporin
|
Molecular Formula | C37H53N7O6 | |
IUPAC Name* |
13-butan-2-yl-20-(1H-indol-3-ylmethyl)-4-(2-methylpropyl)-1,3,6,12,15,19,22-heptazatricyclo[20.4.0.06,10]hexacosane-2,5,11,14,18,21-hexone
|
|
SMILES |
CCC(C)C1NC(=O)C2CCCN2C(=O)C(CC(C)C)NC(=O)C2CCCCN2C(=O)C(Cc2c[nH]c3ccccc23)NC(=O)CCNC1=O
|
|
InChI |
InChI=1S/C37H53N7O6/c1-5-23(4)32-35(48)38-16-15-31(45)40-28(20-24-21-39-26-12-7-6-11-25(24)26)37(50)43-17-9-8-13-29(43)33(46)41-27(19-22(2)3)36(49)44-18-10-14-30(44)34(47)42-32/h6-7,11-12,21-23,27-30,32,39H,5,8-10,13-20H2,1-4H3,(H,38,48)(H,40,45)(H,41,46)(H,42,47)/t23-,27-,28-,29-,30-,32-/m0/s1
|
|
InChIKey |
KJQTUNPWWGOZOW-RGIPJCQOSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 691.87 | ALogp: | 2.1 |
HBD: | 5 | HBA: | 6 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 172.8 | Aromatic Rings: | 5 |
Heavy Atoms: | 50 | QED Weighted: | 0.312 |
Caco-2 Permeability: | -5.565 | MDCK Permeability: | 0.00002000 |
Pgp-inhibitor: | 0.992 | Pgp-substrate: | 0.311 |
Human Intestinal Absorption (HIA): | 0.413 | 20% Bioavailability (F20%): | 0.01 |
30% Bioavailability (F30%): | 0.959 |
Blood-Brain-Barrier Penetration (BBB): | 0.02 | Plasma Protein Binding (PPB): | 84.77% |
Volume Distribution (VD): | 0.454 | Fu: | 7.40% |
CYP1A2-inhibitor: | 0.002 | CYP1A2-substrate: | 0.07 |
CYP2C19-inhibitor: | 0.195 | CYP2C19-substrate: | 0.067 |
CYP2C9-inhibitor: | 0.587 | CYP2C9-substrate: | 0.833 |
CYP2D6-inhibitor: | 0.046 | CYP2D6-substrate: | 0.142 |
CYP3A4-inhibitor: | 0.962 | CYP3A4-substrate: | 0.191 |
Clearance (CL): | 4.081 | Half-life (T1/2): | 0.737 |
hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.895 |
Drug-inuced Liver Injury (DILI): | 0.147 | AMES Toxicity: | 0.005 |
Rat Oral Acute Toxicity: | 0.99 | Maximum Recommended Daily Dose: | 0.536 |
Skin Sensitization: | 0.061 | Carcinogencity: | 0.016 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.003 |
Respiratory Toxicity: | 0.007 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005139 | 0.475 | D09ZIO | 0.466 | ||||
ENC005343 | 0.475 | D0J7XL | 0.397 | ||||
ENC004971 | 0.438 | D0X9PF | 0.323 | ||||
ENC000975 | 0.436 | D08FJL | 0.319 | ||||
ENC004610 | 0.436 | D0D8XY | 0.315 | ||||
ENC003645 | 0.392 | D0E2OU | 0.312 | ||||
ENC003591 | 0.385 | D02SBQ | 0.305 | ||||
ENC003271 | 0.380 | D0M3FJ | 0.298 | ||||
ENC002515 | 0.380 | D02XIY | 0.294 | ||||
ENC005470 | 0.378 | D0M2YE | 0.286 |